Men vs women with spontaneous intracerebral hemorrhage (ICH) have a higher risk for deep bleeds but a lower risk for poor outcomes.

Dementia risk is nearly 80% higher in stroke survivors than in those without stroke, with risk declining within 1 year but ...

Patients afflicted with intracerebral hemorrhage (ICH) experience potentially devastating neurological sequelae; current therapy for ICH remains supportive. However, hemostatic therapy with ...

CLPH-291 is under clinical development by Cellphire and currently in Phase II for Wiskott-Aldrich Syndrome. According to GlobalData, Phase II drugs for Wiskott-Aldrich Syndrome have a 100% phase ...

After 30 years of disappointment, 2 randomized controlled trials investigating the effect of neurosurgical treatment on functional outcome in patients with intracerebral hemorrhage were published in ...

Stryker Corporation SYK recently inked a definitive agreement to acquire all the issued and outstanding shares of common ...

An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate (MTX), according to a new study. Using data from ...

Researchers have identified six new biomarkers that could detect kidney injury faster and with more sensitivity, advancing safer drug development and improving health outcomes for patients. The new ...

The SWITCH trial by Jürgen Beck and colleagues showed a trend towards improved 6-month outcome (although not statistically significant) when deep intracerebral haemorrhage was treated with ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. We respectfully disagree ...

After Donald Trump suggested he might take over Greenland by force, the consensus among the island’s population appears to be bewilderment and anxiety. By Jeffrey Gettleman and Maya Tekeli ...